Jam

Regeneron and Sanofi announced positive Phase 4 trial results for Dupixent in treating moderate-to-severe atopic dermatitis in adults and adolescents with skin of color. The DISCOVER trial, involving 120 patients, showed significant improvements in disease severity, itch reduction, and post-inflammatory hyperpigmentation. The safety profile aligned with previous findings. This marks a significant advancement in treating this often-underserved population.

Republic Bank hosted its fifth annual Juneteenth event in Louisville, Kentucky, in partnership with Kentucky African Americans Against Cancer (KAAAC) and other organizations. They provided free health screenings and educational resources, particularly for West Louisville residents, focusing on prostate and oral health. This initiative builds on their commitment to community engagement and supporting local businesses.

Sandisk Corporation (NASDAQ: SNDK) will present at the Mizuho Technology Conference on June 11, 2025, at 8:15 a.m. PT / 11:15 a.m. ET. A live webcast will be available on Sandisk’s Investor Relations website. An archived replay will be accessible after the presentation. Sandisk is a leader in flash solutions and memory technology, empowering individuals and businesses.

Grupo Aeroportuario del Pacífico (GAP) finalized its passenger tariff review and committed investments for Montego Bay’s airport (2026-2030). Passenger charges will increase annually, reaching $19.07 in 2030. Significant capital development spending is planned, totaling $118.1 million, with $38.4 million allocated in 2026. These investments support GAP’s long-term aviation sector growth strategy.

Empress Royalty Corp. (EMPR) announced strategic moves to incentivize key personnel. The company granted 1,400,000 stock options at $0.68, vesting over three years, and 1,750,000 restricted share units (RSUs) and 650,000 deferred share units (DSUs), vesting over two years. These initiatives aim to align employee interests with long-term shareholder value, demonstrating Empress’ commitment to rewarding performance and fostering a culture of ownership. Empress focuses on gold and silver investments using royalty and streaming models.

Draganfly Inc. announced the partial exercise of the over-allotment option from its recent US$3.6 million public offering. Maxim Group LLC purchased an additional 100,000 common shares at US$2.09 per share, generating US$209,000. Proceeds will fund operations, growth initiatives, product development, and potential strategic acquisitions. The offering was executed under a prior shelf registration, with securities sold exclusively in the U.S.

PENN Entertainment and HG Vora are aligned on director nominees, Johnny Hartnett and Carlos Ruisanchez, for the upcoming 2025 Annual Meeting. Following an ISS report, PENN urges shareholders to vote for these candidates, who they feel are best positioned to execute the company’s strategic plan. PENN also expressed concerns regarding William Clifford’s candidacy and highlighted issues with HG Vora’s institutional waivers.

Shoal Point Energy (SHP) clarifies its operational costs, exceeding $100,000 annually for CSE listing, including legal, accounting, and auditing expenses. The company faces potential regulatory actions, including a Cease Trade Order and delisting, if it fails to comply. Simultaneously, Shoal Point is engaged in a $483 million lawsuit against the Newfoundland government over alleged expropriation of oil and gas assets.

PKS Investments, a Binah Capital Group company, is a finalist in two categories for the 2025 Wealth Management Industry Awards (“The Wealthies”). PKS is recognized for its Transition Support/Transition Services and CEO Katherine Flouton is a finalist for Chief Executive of the Year. This highlights PKS’s expertise in supporting advisors and leadership within the wealth management sector, showcasing Binah Capital’s commitment to empowering independent financial advisors. Winners will be announced September 4th in NYC.

Venus Concept is raising capital through a registered direct offering. The company aims to raise $1.15 million initially by selling common stock at $2.65 per share, with an additional $2.3 million possible through warrants. The offering, which is expected to close around June 9, 2025, will provide funds for general corporate purposes. Venus Concept, a medical aesthetic technology provider in over 60 countries, offers a range of devices and is driven by investors in the healthcare industry.